How to buy 23andMe Holding stock
Learn how to easily invest in 23andMe Holding stock.
Genetic testing company 23andMe is going public via a special purpose acquisition company (SPAC). We'll update this page as new information becomes available.
How to buy 23andMe Holding stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ME. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
23andMe Holding stock price (NASDAQ: ME)Use our graph to track the performance of ME stocks over time.
23andMe Holding shares at a glance
|Latest market close||$1.00|
|52-week range||$0.96 - $3.50|
|50-day moving average||$1.57|
|200-day moving average||$2.15|
|Wall St. target price||$4.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.70|
Buy 23andMe Holding stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy 23andMe Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
23andMe Holding price performance over time
|1 week (2023-09-15)||-9.09%|
|1 month (2023-08-24)||-4.76%|
|3 months (2023-06-23)||-39.02%|
|6 months (2023-03-24)||-55.16%|
|1 year (2022-09-23)||-63.90%|
|2 years (2021-09-24)||-89.22%|
|3 years (2020-09-20)||N/A|
|5 years (2018-09-20)||N/A|
23andMe Holding financials
|Revenue TTM||$295.8 million|
|Gross profit TTM||$132.9 million|
|Return on assets TTM||-21.95%|
|Return on equity TTM||-42.72%|
|Market Capitalization||$529.2 million|
TTM: trailing 12 months
23andMe Holding share dividends
We're not expecting 23andMe Holding to pay a dividend over the next 12 months.
23andMe Holding share price volatility
Over the last 12 months, 23andMe Holding's shares have ranged in value from as little as $0.9601 up to $3.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 23andMe Holding's is 1.304. This would suggest that 23andMe Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put 23andMe Holding's beta into context you can compare it against those of similar companies.
- Genetic Technologies (GENE.US): 0.5755
- Helix Energy Solutions Group (HLX.US): 2.8067
- Natera (NTRA.US): 1.1055
23andMe Holding overview
23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to enhance patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing intellectual property associated with identified drug targets related to drug candidates under clinical development. The company's therapeutics product portfolio comprises 23ME-00610 (P006), a humanized monoclonal antibody, which is in phase 1/2a clinical trials to interfere with the ability of CD200R1 to interact with CD200 in cancer cells; and GSK6097608, an antibody that targets CD96 for attenuating T and NK cell anti-tumor immune responses.
23andMe Holding in the news
23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
Frequently asked questionsWhat percentage of 23andMe Holding is owned by insiders or institutions?
Currently 5% of 23andMe Holding shares are held by insiders and 46.654% by institutions. How many people work for 23andMe Holding?
Latest data suggests 758 work at 23andMe Holding. When does the fiscal year end for 23andMe Holding?
23andMe Holding's fiscal year ends in March. Where is 23andMe Holding based?
23andMe Holding's address is: 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is 23andMe Holding's ISIN number?
23andMe Holding's international securities identification number is: US90138Q1085
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert